Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 23;12(12):1732.
doi: 10.3390/biom12121732.

Emerging Roles of the Unique Molecular Chaperone Cosmc in the Regulation of Health and Disease

Affiliations
Review

Emerging Roles of the Unique Molecular Chaperone Cosmc in the Regulation of Health and Disease

Ting Xiang et al. Biomolecules. .

Abstract

The core-1 β1-3galactosyltransferase-specific chaperone 1 (Cosmc) is a unique molecular chaperone of core-1 β1-3galactosyltransferase(C1GALT1), which typically functions inside the endoplasmic reticulum (ER). Cosmc helps C1GALT1 to fold correctly and maintain activity. It also participates in the synthesis of the T antigen, O-glycan, together with C1GALT1. Cosmc is a multifaceted molecule with a wide range of roles and functions. It involves platelet production and the regulation of immune cell function. Besides that, the loss of function of Cosmc also facilitates the development of several diseases, such as inflammation diseases, immune-mediated diseases, and cancer. It suggests that Cosmc is a critical control point in diseases and that it should be regarded as a potential target for oncotherapy. It is essential to fully comprehend Cosmc's roles, as they may provide critical information about its involvement in disease development and pathogenesis. In this review, we summarize the recent progress in understanding the role of Cosmc in normal development and diseases.

Keywords: C1GALT1; Cosmc; O-glycosylation; Tn antigen; chaperonin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic diagram of the biosynthesis of O-glycan. O-glycosylation is normally initiated in the Golgi apparatus. With the assistance of the molecular chaperone Cosmc, C1GALT1 adds Gal from UDP-Gal to the Tn antigen to form the T antigen, which is extended by adding other sugars to produce normal O-glycans. Without Cosmc, the function of C1GALT1 would be lost, resulting in the generation of Tn and/or Sialyl Tn antigen, which is usually associated with the molecular mechanisms of the development of various diseases or tumors.
Figure 2
Figure 2
Model of Cosmc structure. The N-terminal domain of Cosmc (dark blue) is responsible for interacting with C1GALT1 (red peptide) for chaperone function, and the C-terminal domain (light blue) mediates oligomerization and Zn2+ binding.
Figure 3
Figure 3
Working model for Cosmc function. Human Cosmc is located in the ER, where it interacts with the activated C1GALT1. Activated C1GALT1 is inserted into the Golgi apparatus and is involved in the synthesis of core-1 O-glycans (T antigens). When Cosmc is mutated and dysfunctional, misfolded C1GALT1 aggregates in the endoplasmic reticulum and is retrotranslocated from the endoplasmic reticulum to the cytosol, where it is ubiquitinated and degraded by the proteasomal machinery.
Figure 4
Figure 4
The colon has a two-layered mucus system; the outer layer is infiltrated by intestinal bacteria, and the inner layer is unaffected by bacteria and physically separates them from the epithelium. The lack of defects in this inner MUC2 mucin, which is the main mucus component of the intestine, disrupts the protective properties of the inner colonic mucus layer, allowing direct contact between bacteria and epithelial cells to cause inflammation and bleeding.

References

    1. Eichler J. Protein glycosylation. Curr. Biol. 2019;29:R229–R231. doi: 10.1016/j.cub.2019.01.003. - DOI - PubMed
    1. Theodoratou E., Thaçi K., Agakov F., Timofeeva M.N., Štambuk J., Pučić-Baković M., Vučković F., Orchard P., Agakova A., Din F.V.N., et al. Glycosylation of plasma IgG in colorectal cancer prognosis. Sci. Rep. 2016;6:28098. doi: 10.1038/srep28098. - DOI - PMC - PubMed
    1. Stotter B.R., Talbot B.E., Capen D.E., Artelt N., Zeng J., Matsumoto Y., Endlich N., Cummings R.D., Schlondorff J.S. Cosmc-dependent mucin-type O-linked glycosylation is essential for podocyte function. Am. J. Physiol. Renal. Physiol. 2020;318:F518–F530. doi: 10.1152/ajprenal.00399.2019. - DOI - PMC - PubMed
    1. Zhang L., Zhang Y., Hagen K.G.T. A Mucin-type O-Glycosyltransferase Modulates Cell Adhesion during Drosophila Development. J. Biol. Chem. 2008;283:34076–34086. doi: 10.1074/jbc.M804267200. - DOI - PMC - PubMed
    1. Magalhães A., Duarte H.O., Reis C.A. The role of O-glycosylation in human disease. Mol. Asp. Med. 2021;79:100964. doi: 10.1016/j.mam.2021.100964. - DOI - PubMed

Publication types

Substances

LinkOut - more resources